Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/15/2008 | EP1083882B1 Poly-l-lysine grafted with lactose or galactose-polyethylene glycol as polymeric gene carrier |
10/15/2008 | EP0918546B1 Improvements in or relating to contrast agents |
10/15/2008 | EP0841946B2 Methods for treatment of allergic asthma |
10/15/2008 | CN101287502A Compositions and methods for treating HIV infection with cupredoxin and cytochrame c |
10/15/2008 | CN101287500A Multi-drug ligand conjugates |
10/15/2008 | CN101287499A Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutical effective lipids |
10/15/2008 | CN101287498A Psma抗体-药物缀合物 Psma antibody - drug conjugates |
10/15/2008 | CN101287497A Lipid complexes coated with peg and their use |
10/15/2008 | CN101287496A Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
10/15/2008 | CN101287484A Binding agents which inhibit myostatin |
10/15/2008 | CN101287473A Agent for applying to mucosa and method for production thereof |
10/15/2008 | CN101287470A Improved testosterone gel and method of use |
10/15/2008 | CN101287466A Immediate release therapeutic systems for improved oral absorption of 7-[(E)-t-butyloxyminomethyl] camptothecin |
10/15/2008 | CN101287447A Aqueous anaesthetic propofol composition comprising propofol |
10/15/2008 | CN101287443A Pulse releasing system controlled by pH, preparation method and application thereof |
10/15/2008 | CN101284909A Polycaprolactone/polyacrylamide graft copolymer and uses thereof |
10/15/2008 | CN101284885A Amphipathic cyclodextrin polymers, preparation method and use |
10/15/2008 | CN101284136A Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
10/15/2008 | CN101284135A Mono-modified polyethyleneglycol-insulin complexes and preparation method thereof |
10/15/2008 | CN101284134A Carrier for gene transmission and preparation method thereof and application |
10/15/2008 | CN101284133A Drug carried target cationic polymer for injections and modified by integrin ligand |
10/15/2008 | CN101284132A Application of high molecule absorbent resin in medicine for external application and application process thereof |
10/15/2008 | CN101284131A Application of cyanoacrylate glycol ester in preparing medicine carrier |
10/15/2008 | CN101284128A Medicine for relieving or neutralizing the effect of alcohol and resisting intoxication and preparation method thereof |
10/15/2008 | CN101284123A Yanghe decoction oral formulations and preparation method thereof |
10/15/2008 | CN101284103A Attapulgite delousing ointment |
10/15/2008 | CN101284085A Plaster for curing the bone fracture |
10/15/2008 | CN101284067A Chinese medicine wash-out effervescent tablet for disinfection and anti-inflammation of the wound surface and preparation method thereof |
10/15/2008 | CN101284051A Ji Chuan Jian oral preparation and preparation method thereof |
10/15/2008 | CN101284046A Thrombus clear health soft capsules |
10/15/2008 | CN101284035A Xuesaitong orally-administered freeze-dried tablets and preparation method thereof |
10/15/2008 | CN101284027A Preparation method of capsules for reducing blood fat |
10/15/2008 | CN101284011A Oleanolic acid orally disintegrating tablet and preparation method thereof |
10/15/2008 | CN101284009A Cefoperazone sodium and sulbactam sodium combination and preparation method thereof |
10/15/2008 | CN101284006A Medicine composition for treating eye disease |
10/15/2008 | CN101284003A Medicinal composition containing andrographolide derivatives and preparation method thereof and application |
10/15/2008 | CN101283993A Use of the diabecron sustained-release tablet in treating the type 2 diabetes mellitus |
10/15/2008 | CN101283991A Orally-disintegrating tablet and manufacturing method thereof |
10/15/2008 | CN101283990A R-albuterol hydrochloride sustained-released fast disintegrating oral tablet and preparation method thereof |
10/15/2008 | CN101283987A Chloroquine liposomes freeze-dried powder injection and preparation method thereof |
10/15/2008 | CN101283986A Omeprazole freeze-dried powder injection and preparation method thereof |
10/15/2008 | CN101283985A Enteric oral vaccine for fishing gear and preparation method thereof |
10/15/2008 | CN101283984A Core particle object coated by fungicide and polymer with high biological usage |
10/15/2008 | CN101283982A Fenofibrate nanometer suspension and preparation method thereof |
10/15/2008 | CN101283981A Sustained-release injection containing antibiotic |
10/15/2008 | CN101283980A Propylgallate and sodium chloride injection |
10/15/2008 | CN101283978A Anticancer sustained-release gel injection containing platinum compound |
10/15/2008 | CN101283977A Sustained-release gel injection loaded with platinum compound and alkyl agent |
10/15/2008 | CN101283976A Anticancer sustained-release gel injection containing taxone medicine |
10/15/2008 | CN101283975A Anticancer sustained-release gel injection containing neonatal blood vessel inhibitor |
10/15/2008 | CN101283974A Anticancer sustained-release gel injection and preparation method thereof |
10/15/2008 | CN101283973A Sustained-release injection containing netilcosin |
10/15/2008 | CN101283972A Sustained-release injection containing antibiotic and application thereof |
10/15/2008 | CN101283971A Sustained-release injection containing antibiotic lincomycin and application thereof |
10/15/2008 | CN101283970A Sustained-release injection containing antibiotic and application thereof |
10/15/2008 | CN101283969A Sustained-release injection containing estomycin |
10/15/2008 | CN101283968A Tolterodine fumarate oral solid preparation and preparation method thereof |
10/15/2008 | CN101283967A Basis particles and orally-disintegrating tablet containing them |
10/15/2008 | CN100425304C Chinese medicine permeation promoting material, transdermal medicine with the material and its prepn process |
10/15/2008 | CN100425289C Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin |
10/15/2008 | CN100425284C Methods for glucagon suppression |
10/15/2008 | CN100425283C Stable pharmaceutical composition comprising erythropoietin |
10/15/2008 | CN100425248C Externally-applied colliculus musk-oil agent for treating burn and scald |
10/15/2008 | CN100425235C Enteric omeprazole micropill and its preparing method |
10/15/2008 | CN100425232C Buccale tablet preparation and its making method |
10/15/2008 | CN100425229C Local medicine preparation containing antiinfective medicine composition and its preparing method |
10/15/2008 | CN100425228C Dispersion tablets and its prepn. method |
10/15/2008 | CN100425225C Method for promoting liposome lymph absorption and reducing normal lymph node accumulation |
10/14/2008 | US7435792 Hybrid proteins that migrate retrogradely and transynaptically into the CNS |
10/14/2008 | US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury |
10/14/2008 | US7435723 In situ administering into vascular system by injection; gene therapy; controlling gene expression |
10/14/2008 | US7435720 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
10/14/2008 | US7435585 Auto-stimulating cells and methods for making and using the same |
10/14/2008 | US7435427 Contains at least 2 lipidic excipients, one of them being an hydrophilic excipient (having a high HLB value) and the other an oily excipient; stearoyl macroglyceride and soyabean oil for example |
10/14/2008 | US7435426 Micron sized bicarbonate particles and slurrys containing the same |
10/14/2008 | US7435422 protein free; an alcohol (or polyhydroxyalcohol such as dextran), a sugar (mono/polysaccharide), and a buffer; lyophilization; further comprising a soybean peptone |
10/14/2008 | US7435410 Methods of treatment with interferson and albumin fusion protein |
10/14/2008 | CA2430995C Reversible gelling system for ocular drug delivery |
10/14/2008 | CA2376849C Method of inhibiting leakage of drug encapsulated in liposomes |
10/14/2008 | CA2363038C Granulate with high content of l-carnitine or an alkanoyl l-carnitine, particularly suitable for the production of tablets by direct compression |
10/14/2008 | CA2354576C Pharmaceutical preparation for inhalation of an opioid |
10/14/2008 | CA2338680C Medicinal aerosol formulations |
10/14/2008 | CA2336139C Large porous particles emitted from an inhaler |
10/14/2008 | CA2318128C Oral liquid compositions |
10/14/2008 | CA2279279C Lipid complexes and liposomes of highly insoluble platinum complexes |
10/14/2008 | CA2238937C Delivery system for localized administration of medicaments to the upper respiratory tract |
10/14/2008 | CA2192782C Production of microspheres |
10/09/2008 | WO2008122039A2 Selenocysteine mediated hybrid antibody molecules |
10/09/2008 | WO2008121951A2 Packaged film dosage unit containing a complexate |
10/09/2008 | WO2008121926A1 Particle formulations and uses thereof |
10/09/2008 | WO2008120815A1 Targeting agent for cancer cell or cancer-associated fibroblast |
10/09/2008 | WO2008120812A1 Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex |
10/09/2008 | WO2008120741A1 Sustained release preparation of basic fibroblast growth factor |
10/09/2008 | WO2008120736A1 Transpulmonary liposome for controlling drug arrival |
10/09/2008 | WO2008120724A1 Medicinal solid-dispersion preparation |
10/09/2008 | WO2008120717A1 Liquid nutritional composition containing sodium at high concentration and method of producing the same |
10/09/2008 | WO2008120711A1 Tamibarotene capsule preparation |
10/09/2008 | WO2008120602A1 Process for production of porous body and uses thereof |
10/09/2008 | WO2008120562A1 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia |
10/09/2008 | WO2008120548A2 Oral disintegrating tablet |